scholarly journals Autism Spectrum Disorders and the Gut Microbiota

Nutrients ◽  
2019 ◽  
Vol 11 (3) ◽  
pp. 521 ◽  
Author(s):  
Antonella Fattorusso ◽  
Lorenza Di Genova ◽  
Giovanni Dell’Isola ◽  
Elisabetta Mencaroni ◽  
Susanna Esposito
Keyword(s):  
Clinical Trials ◽  
Autism Spectrum Disorders ◽  
Gut Microbiota ◽  
Autism Spectrum ◽  
Current Evidence ◽  
Low Grade ◽  
Gut Dysbiosis ◽  
Children With Asd ◽  
Spectrum Disorders

In recent years, there has been an emerging interest in the possible role of the gut microbiota as a co-factor in the development of autism spectrum disorders (ASDs), as many studies have highlighted the bidirectional communication between the gut and brain (the so-called “gut-brain axis”). Accumulating evidence has shown a link between alterations in the composition of the gut microbiota and both gastrointestinal and neurobehavioural symptoms in children with ASD. The aim of this narrative review was to analyse the current knowledge about dysbiosis and gastrointestinal (GI) disorders in ASD and assess the current evidence for the role of probiotics and other non-pharmacological approaches in the treatment of children with ASD. Analysis of the literature showed that gut dysbiosis in ASD has been widely demonstrated; however, there is no single distinctive profile of the composition of the microbiota in people with ASD. Gut dysbiosis could contribute to the low-grade systemic inflammatory state reported in patients with GI comorbidities. The administration of probiotics (mostly a mixture of Bifidobacteria, Streptococci and Lactobacilli) is the most promising treatment for neurobehavioural symptoms and bowel dysfunction, but clinical trials are still limited and heterogeneous. Well-designed, randomized, placebo-controlled clinical trials are required to validate the effectiveness of probiotics in the treatment of ASD and to identify the appropriate strains, dose, and timing of treatment.

scholarly journals Management of Gut Microbiota to Improve Sleep Dysfunction for Children with Autism-Spectrum Disorders

2021 ◽  
Vol 9 (4) ◽  
pp. 85-91
Author(s):  
Vasanth Senthilraja ◽  
Ethan Yang ◽  
Akshay Jakkidi Reddy ◽  
Eric Liu ◽  
Himanshu Wagh
Keyword(s):  
Autism Spectrum Disorders ◽  
Gut Microbiota ◽  
Sleep Disorders ◽  
Children With Autism ◽  
Autism Spectrum ◽  
Hormone Production ◽  
Sleep Dysfunction ◽  
Children With Asd ◽  
Significant Difference ◽  
Spectrum Disorders

Many children with Autism-Spectrum Disorders (ASD) struggle with sleep dysfunction. This can be caused by a lack of important gut microbiota (GM) that have the ability to influence functions of the nervous system through the gut-brain axis. The metabolites of GM function are responsible for influencing the production of pertinent sleep hormones, such as melatonin and serotonin. The research has identified lower abundance levels of the gut microbiota species Faecalibacterium and Agathobacter in children with ASD that struggled with sleep disorders. When exploring their impact on sleep hormone production, a positive correlation was identified between these species of GM and melatonin levels, which regulates circadian sleep cycles. In addition, a negative correlation was observed between these species of GM and serotonin levels, which high levels of can lead to wakefulness and sleep dysfunction. To improve GM levels in children with ASD, a Bimuno® galactooligosaccharide (B-GOS®) prebiotic intervention was tested in children with ASD. While this intervention led to improved GM levels and increased levels of Faecalibacterium growth, a significant difference was not noticed between groups. Furthermore, an analysis of probiotic intervention studies in various individuals revealed the ability to improve sleep metric scores through consumption of probiotics. These findings can be further explored in children with ASD for potential treatments for sleep disorders.

Role of the gut-brain axis in the eating behavior of children with autism spectrum disorders

2017 ◽  
Vol 13 (3) ◽  
Author(s):  
Justyna Siwek ◽  
Aleksandra Kawala-Janik ◽  
Piotr Walecki
Keyword(s):  
Autism Spectrum Disorders ◽  
Digestive System ◽  
Bacterial Flora ◽  
Food Products ◽  
Autism Spectrum ◽  
Control Group ◽  
Healthy Children ◽  
Children With Asd ◽  
Spectrum Disorders

AbstractIntroduction:The occurrence of autism spectrum disorders (ASD) has significantly increased in the last few years. One of the common problems in this group are eating disorders and ailments from the gastrointestinal systems. According to some studies, these problems have a significant impact on the occurrence and severity of symptoms in the neurological system, so it is crucial to increase the attention paid on the role of diet in the treatment of this disease. One of the theories connects ASD with disorders of the digestive system and the intestinal bacterial flora. This theory is based on the gut-brain axis, which means the interaction between the gastrointestinal and nervous systems.Objectives:To demonstrate the differences in behavior habits, interest in nutrition, and frequency of consumption of food products between children suffering from ASD and healthy children.Materials and methods:The study was conducted among 44 children suffering from ASD and 33 healthy children as a control group. Data were collected using a questionnaire that was specially designed for this study. The questionnaire contained questions about eating habits and the frequency of consumption of selected food products.Results:Parents of healthy children showed more interest in their children’s way of feeding and nutritional recommendations compared to parents of children with ASD (4% and 11.3%, respectively). In addition, 24.3% more children with ASD consulted with a nutritionist compared to the control group. Complaints of the digestive system were 21.1% more likely by children with ASD. Children suffering from ASD were characterized by a higher intake of red meat and giblets and less frequent consumption of milk and milk products compared to the control group. There were no statistically significant differences between the study group and the control group in terms of frequency of consumption of products, which are the source of gluten, artificial food additives-preservatives, and artificial colors.Conclusions:There are differences in the habits and eating behaviors and the frequency of consumption of selected food products between a group of children with ASD and a group of healthy children.

scholarly journals Visual preference for social vs. non-social images in young children with autism spectrum disorders. An eye tracking study

PLoS ONE ◽  
2021 ◽  
Vol 16 (6) ◽  
pp. e0252795
Author(s):  
Julia Vacas ◽  
Adoración Antolí ◽  
Araceli Sánchez-Raya ◽  
Carolina Pérez-Dueñas ◽  
Fátima Cuadrado
Keyword(s):  
Autism Spectrum Disorders ◽  
Young Children ◽  
Eye Tracking ◽  
Autism Spectrum ◽  
Circumscribed Interests ◽  
Object A ◽  
Children With Asd ◽  
Social Images ◽  
Spectrum Disorders

Autism Spectrum Disorders (ASD) are associated to social attention (SA) impairments. A gaze bias to non-social objects over faces has been proposed as an early marker of ASD. This bias may be related to the concomitant circumscribed interests (CI), which question the role of competing objects in this atypical visual behavior. The aim of this study was to compare visual attention patterns to social and non-social images in young children with ASD and matched typical controls (N = 36; age range 41–73 months) assessing the role of emotion in facial stimuli and the type of competing object. A paired preference task was designed pairing happy, angry, and neutral faces with two types of objects (related or not related to autism CI). Eye tracking data were collected, and three indexes were considered as dependent variables: prioritization (attentional orientation), preference, and duration (sustained attention). Results showed that both groups had similar visual pattern to faces (prioritization, more attention and longer visits to faces paired with objects non-related to their CI); however, the ASD group attended to faces significantly less than controls. Children with ASD showed an emotional bias (late orientation to angry faces and typical preference for happy faces). Finally, objects related to their CI captured attention in both groups, significantly reducing SA in children with ASD. Atypical SA is present in young children with ASD regardless the competing non-social object. Identifying strengths and difficulties in SA in this population may have substantial repercussion for early diagnosis, intervention, and ultimately prognosis.

The Role of Serotonin in Autism-Spectrum Disorders

CNS Spectrums ◽  
1997 ◽  
Vol 2 (5) ◽  
pp. 25-42 ◽  
Author(s):  
Marc N. Potenza ◽  
Christopher J. Mcdougle
Keyword(s):  
Clinical Trials ◽  
Autism Spectrum Disorders ◽  
Pervasive Developmental Disorders ◽  
Developmental Disorders ◽  
Autism Spectrum ◽  
Adolescents And Adults ◽  
Spectrum Disorders ◽  
Serotonergic Dysfunction

AbstractWhile the etiologies of pervasive developmental disorders (PDDs) appear complicated, multifactorial, and relatively poorly understood research over the last 30 to 40 years has implicated certain neurochemicals in the pathophysiology of these diseases. From these studies, a great deal of evidence has emerged supporting a role for serotonergic dysfunction in individuals with autism and related disorders. Recent clinical trials of drugs influencing serotonergic systems have demonstrated promising effects in children, adolescents, and adults with PDDs.

scholarly journals Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies

Molecules ◽  
2019 ◽  
Vol 24 (23) ◽  
pp. 4262 ◽  
Author(s):  
Michele Malaguarnera ◽  
Omar Cauli
Keyword(s):  
Clinical Trials ◽  
Autism Spectrum Disorders ◽  
Randomized Clinical Trials ◽  
Genetic Disorders ◽  
Prospective Trial ◽  
Autism Spectrum ◽  
Amino Acid Derivative ◽  
Current Evidence ◽  
Clinical Effects ◽  
Spectrum Disorders

Carnitine is an amino acid derivative, which plays several important roles in human physiology, in the central nervous system, and for mitochondrial metabolism, in particular. Altered carnitine metabolic routes have been associated with a subgroup of patients with autism spectrum disorders (ASD) and could add to the pathophysiology associated with these disorders. We review the current evidence about the clinical effects of carnitine administration in ASD in both non-syndromic forms and ASD associated with genetic disorders. Two randomized clinical trials and one open-label prospective trial suggest that carnitine administration could be useful for treating symptoms in non-syndromic ASD. The effect of carnitine administration in ASD associated with genetic disorders is not conclusive because of a lack of clinical trials and objectives in ASD evaluation, but beneficial effects have also been reported for other comorbid disorders, such as intellectual disability and muscular strength. Side effects observed with a dose of 200 mg/kg/day consisted of gastro-intestinal symptoms and a strong, heavy skin odor. Doses of about 50–100 mg/kg/day are generally well tolerated. Further clinical trials with the identification of the subgroup of ASD patients that would benefit from carnitine administration are warranted.

scholarly journals Complementary and Alternative Treatments for Autism Spectrum Disorders: A Review for Parents and Clinicians

2020 ◽  
Vol 9 (3) ◽  
pp. 142-173
Author(s):  
M.A. Zhukova ◽  
O.I. Talantseva ◽  
T.I. Logvinenko ◽  
O.S. Titova ◽  
E.L. Grigorenko
Keyword(s):  
Autism Spectrum Disorders ◽  
Sleep Problems ◽  
Autism Spectrum ◽  
Current Evidence ◽  
Alternative Treatments ◽  
Complementary And Alternative Therapy ◽  
Children With Asd ◽  
Pubmed Database ◽  
Spectrum Disorders ◽  
Complementary And Alternative

Complementary and alternative therapy (CAT) methods for children with autism spectrum disorders (ASD) are widespread in European countries and the Russian Federation; however, their efficacy and safety is not routinely considered by parents and clinicians when recommended or used. The current narrative review presents the most widely known CAT interventions for children with ASD synthesizing data from meta-analyses, systematic reviews, and randomized controlled trials obtained from the PubMed database based on the safety-efficacy model. We have found that, of the reviewed CATs, only the melatonin intervention can be considered safe and effective for children with ASD with comorbid sleep problems. The methods that were classified as safe but had inconclusive efficacy are recommended to be implemented only when they do not interfere with front line treatment for ASD, Applied Behavior Analysis (ABA). Methods with the lack of current evidence for the efficacy such as auditory integration therapies, bioacoustic correction, sensory integration therapy, micropolarization, animal assisted therapy, and dietary interventions should not be recommended as alternative treatments and can only be used as complimentary to ABA-based interventions. We advise against the use of chelation, hyperbaric oxygen therapy, and holding therapy due their documented harmful psychological and physical effects. When considering CAT for ASD we recommend parents and clinicians use the criteria suggested by Lofthouse and colleagues [59]: only the therapies that are safe, easy, cheap, and sensible can be recommended and used, as opposed to therapies that are risky, unrealistic, difficult, or expensive that should not be recommended or utilized.

scholarly journals The Potential Role of Probiotics in the Management of Childhood Autism Spectrum Disorders

2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
J. William Critchfield ◽  
Saskia van Hemert ◽  
Michael Ash ◽  
Linda Mulder ◽  
Paul Ashwood
Keyword(s):  
Autism Spectrum Disorders ◽  
Gut Microbiota ◽  
Barrier Function ◽  
Sleep Disturbances ◽  
Intestinal Barrier ◽  
Autism Spectrum ◽  
Intestinal Barrier Function ◽  
Children With Asd ◽  
Gi Symptoms ◽  
Spectrum Disorders

Gastrointestinal (GI) dysfunction has been reported in a substantial number of children with autism spectrum disorders (ASD). Activation of the mucosal immune response and the presence of abnormal gut microbiota are repeatedly observed in these children. In children with ASD, the presence of GI dysfunction is often associated with increased irritability, tantrums, aggressive behaviour, and sleep disturbances. Moreover, modulating gut bacteria with short-term antibiotic treatment can lead to temporary improvement in behavioral symptoms in some individuals with ASD. Probiotics can influence microbiota composition and intestinal barrier function and alter mucosal immune responses. The administration of probiotic bacteria to address changes in the microbiota might, therefore, be a useful novel therapeutic tool with which to restore normal gut microbiota, reduce inflammation, restore epithelial barrier function, and potentially ameliorate behavioural symptoms associated with some children with ASD. In this review of the literature, support emerges for the clinical testing of probiotics in ASD, especially in the context of addressing GI symptoms.

Disfluency Characteristics Observed in Young Children With Autism Spectrum Disorders: A Preliminary Report

2010 ◽  
Vol 20 (2) ◽  
pp. 42-50 ◽  
Author(s):  
Laura W. Plexico ◽  
Julie E. Cleary ◽  
Ashlynn McAlpine ◽  
Allison M. Plumb
Keyword(s):  
Autism Spectrum Disorders ◽  
Young Children ◽  
Children With Autism ◽  
Descriptive Study ◽  
Autism Spectrum ◽  
Typically Developing ◽  
Children With Asd ◽  
Young Children With Autism ◽  
Spectrum Disorders ◽  
Developmental Stuttering

This descriptive study evaluates the speech disfluencies of 8 verbal children between 3 and 5 years of age with autism spectrum disorders (ASD). Speech samples were collected for each child during standardized interactions. Percentage and types of disfluencies observed during speech samples are discussed. Although they did not have a clinical diagnosis of stuttering, all of the young children with ASD in this study produced disfluencies. In addition to stuttering-like disfluencies and other typical disfluencies, the children with ASD also produced atypical disfluencies, which usually are not observed in children with typically developing speech or developmental stuttering. (Yairi & Ambrose, 2005).

Critical role of dysfunctional mitochondria and defective mitophagy in autism spectrum disorders

2021 ◽  
Vol 168 ◽  
pp. 138-145
Author(s):  
Yuan-Mei Wang ◽  
Ming-Yue Qiu ◽  
Qing Liu ◽  
Huang Tang ◽  
Hong-Feng Gu
Keyword(s):  
Autism Spectrum Disorders ◽  
Critical Role ◽  
Autism Spectrum ◽  
Spectrum Disorders

scholarly journals Oral Health and Autism Spectrum Disorders: A Unique Collaboration between Dentistry and Occupational Therapy

2020 ◽  
Vol 18 (1) ◽  
pp. 135
Author(s):  
Dominique H. Como ◽  
Leah I. Stein Duker ◽  
José C. Polido ◽  
Sharon A. Cermak
Keyword(s):  
Autism Spectrum Disorders ◽  
Oral Health ◽  
Emotional Regulation ◽  
Occupational Therapists ◽  
Autism Spectrum ◽  
Clinic Visit ◽  
Children With Asd ◽  
Increased Risk ◽  
Dental Practitioners ◽  
Spectrum Disorders

Children with autism spectrum disorders (ASD) are at risk for oral health disparities. With the dramatic rise in ASD prevalence to 1 in 54 children, it is likely that an increasing number of dental practitioners will encounter or be asked to treat children with ASD. This paper reviews explanations related to the increasing prevalence of ASD, provides reasons why children with ASD are at increased risk for poor oral health, and discusses unique interprofessional collaborations between dental practitioners and occupational therapists. Occupational therapists and dentists can work together to plan modifications to the dental environment or adapt dental protocols to reduce some of the barriers encountered by those with ASD, provide desensitization strategies before the clinic visit, or help a child with emotional regulation during clinical treatments.

Sign in / Sign up

Export Citation Format

Share Document